Aurobindo Pharma Ltd
BSE:524804

Watchlist Manager
Aurobindo Pharma Ltd Logo
Aurobindo Pharma Ltd
BSE:524804
Watchlist
Price: 1 146.25 INR 0.52%
Market Cap: 671.6B INR

Profitability Summary

Aurobindo Pharma Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Aurobindo Pharma Ltd

Margins Comparison
Aurobindo Pharma Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Aurobindo Pharma Ltd
NSE:AUROPHARMA
670.8B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.7B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.2B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Aurobindo Pharma Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Aurobindo Pharma Ltd
NSE:AUROPHARMA
670.8B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.7B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.2B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Aurobindo Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate